Preliminary Results Yield 43% Overall Response Rates (via RECIST) in the Efficacy Population Data Demonstrate REM-422, the ...

PreliminaryResultsYield43%OverallResponseRates(viaRECIST)intheEfficacyPopulationDataDemonstrateREM-422,theFirst-in-ClassSmallMoleculeMYBmRNADegrad ...

Researchers have characterized the shape and structure of LNPs in unprecedented detail, revealing that the particles come in ...

Neurons have dominated neuroscience research for decades, but a growing body of evidence suggests that a group of ...

Gilead Sciences, Inc. will present new research that reinforces its commitment to advancing innovation for people living with liver disease at The Liver Meeting® 2025, hosted by the American ...

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences exploring how ribonucleic acid, known as RNA, can be harnessed to develop ...

The oncology pipeline is marked by heterogeneity and complexity (1). Moving forward, pharmaceutical scientists must navigate the intersection of advanced biology, next-generation delivery platforms, ...

Ultima Genomics has transformed highly efficient, production-scale sequencing while reducing the sequencing cost per genome ...

This study presents a useful inventory of genes that are up- and down-regulated in the mouse small intestine (duodenum and ileum) during the first postnatal month; the data were collected and analyzed ...

Founded in 2018, Metagenomi is using a Nobel prize-winning approach developed by Jennifer Doudna and Emmanuelle Charpentier ...

Recognized as a 2025 Top Innovations pick in the Biotechnology category, AVITI24 from Element Biosciences enables true ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb ...